Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Clinical Translation of Stem Cells 2014

Kristin Comella's Biography

Kristin Comella, Chief Scientific Officer, Bioheart, Inc.

Ms. Comella has over 15 years’ experience in corporate entities with expertise in regenerative medicine. She was recently named number 24 according to Terrapin’s list of the Top 50 Global Stem Cell Influencers. Ms. Comella has pioneered a variety of stem cell therapies including cord blood derived cells, bone marrow cells, muscle cells and adipose cells for use in many different applications. She has developed a wide range of regenerative products and techniques that have been successfully implemented into the clinic. She also led the team that gained the first ever FDA approval for clinical trials using a combined cell and gene therapy product. Ms. Comella has been a member of the Bioheart Inc. senior management team since 2004 and is currently serving as the Chief Scientific Officer and board member. Bioheart is a publically traded company focusing on the discovery, development and commercialization of autologous cell therapies for the treatment of degenerative diseases. Since joining Bioheart, she has played a major role in managing the product development, manufacturing and quality systems of cellular products. In addition, Ms. Comella is currently and actively serving on multiple boards in the stem cell arena. She was co-founder and Chief Executive Officer of Stemlogix, LLC for veterinary medicine. Ms. Comella has years of cell culturing experience including building and managing the stem cell laboratory at Tulane University's Center for Gene Therapy. Previously, she worked as a research engineer for Osiris Therapeutics developing stem cell therapies for osteoarthritis. Ms. Comella holds an M.S. in Chemical Engineering from The Ohio State University and a B.S. in Chemical Engineering from the University of South Florida.

Kristin Comella Image

Regenerative Medicine for Veterinary Applications

Monday, 21 April 2014 at 10:45

Add to Calendar ▼2014-04-21 10:45:002014-04-21 11:45:00Europe/LondonRegenerative Medicine for Veterinary ApplicationsClinical Translation of Stem Cells 2014 in Palm Springs, California, USAPalm Springs, California,

The field of regenerative medicine is rapidly growing with an emphasis on stem cell therapies and the promise of cures for everything from acute injuries to chronic degenerative diseases.  The list of indications is expanding as more studies are published to demonstrate safety and efficacy.  Regenerative medicine is the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function.  The concept is that damaged tissue can be restored by using the body’s own healing mechanism to promote repair.  This new branch of medicine may change the course of chronic diseases and standard clinical therapies.  However, with any new therapies, this must be approached cautiously and with scientific data to support the treatment.  This session will discuss the use of stem cell therapies in veterinary applications and the challenges of bringing these products to market.

Add to Calendar ▼2014-04-21 00:00:002014-04-22 00:00:00Europe/LondonClinical Translation of Stem Cells 2014Clinical Translation of Stem Cells 2014 in Palm Springs, California, USAPalm Springs, California,